Using remote directly observed therapy (R-DOT) for optimising asthma therapy.

M. Shields (Belfast, United Kingdom)

Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma
Session: Small airways, long distances and large databases in paediatric asthma
Session type: Oral Presentation
Number: 3448
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Shields (Belfast, United Kingdom). Using remote directly observed therapy (R-DOT) for optimising asthma therapy.. 3448

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Fluticasone/salmeterol combination (FSC) is safe and provides effective long-term (52 week) control in the management of patients with persistent asthma (PA)
Source: Eur Respir J 2001; 18: Suppl. 33, 176s
Year: 2001

Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004

Effectiveness of different models of maintenance therapy for bronchial asthma (BA) in routine clinical practice
Source: Eur Respir J 2007; 30: Suppl. 51, 70s
Year: 2007

Cost consequences of tiotropium plus existing therapy versus existing therapy alone following one year of treatment in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 5s
Year: 2001

Characterization of physical activity (PA) patterns by use of multiple accelerometers in COPD patients undergoing long-term oxygen therapy (LTOT) within a pulmonary rehabilitation (PR) program
Source: Annual Congress 2010 - Physical activity, exercise regimes and outcomes for chronic respiratory disease
Year: 2010


The response to combination therapy treatment regimens in severe/difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 1237-1242
Year: 2008



Improving asthma therapy through targeting more effective control of inflammation - a European consensus
Source: Eur Respir J 2005; 26: Suppl. 49, 253s
Year: 2005

Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma?
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009


Suboptimal asthma control in patients receiving long-term maintenance therapy
Source: Annual Congress 2006 - The challenges of managing asthma in primary care
Year: 2006


Does combination therapy lead to better adherence in asthma?
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010


Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Budesonid/formoterol easyhaler: clinical efficiency and adherence to treatment in patients with partly controlled bronchial asthma (BA).
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017


Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Managing asthma patients: which outcomes matter?
Source: Eur Respir Rev 2008; 17: 53-61
Year: 2008



The importance of the aplication long-therm therapy (LTOT) in COPD tretmant
Source: Eur Respir J 2006; 28: Suppl. 50, 519s
Year: 2006

Does adherence to ICS/LABA therapy affect response to mepolizumab in the treatment of severe asthma?
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019

Resource utilization and economic impact of switching uncontrolled asthma and exacerbating COPD patients on monotherapy to fixed dose combination treatment in Germany
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012

Is occupational therapy (OT) really needed in pulmonary rehabilitation programmes (PRP)?
Source: Eur Respir J 2005; 26: Suppl. 49, 529s
Year: 2005

Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010